ILMN ILLUMINA, INC.

P/E 40.3

Forward P/E 42.55

Price/Sales 7.24

Beta 1.464

Div Yield --

Market Cap --

Company Analysis

Latest News

June 23, 2026

Illumina Appoints Eli Lilly's Chief Scientific Officer to its Board of Directors

Illumina announced it has appointed Dr. Daniel M. Skovronsky to its Board of Directors, effective June 16, 2026. In connection with the appointment, the...